4//SEC Filing
Thompson Travis Alvin 4
Accession 0001415889-25-000928
CIK 0001761612other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:30 PM ET
Size
20.0 KB
Accession
0001415889-25-000928
Insider Transaction Report
Form 4
Thompson Travis Alvin
CHIEF ACCOUNTING OFFICER
Transactions
- Sale
Ordinary Shares
2025-01-03$14.75/sh−159$2,345→ 34,832 total - Award
Employee Stock Option (right to buy)
2025-01-02+43,500→ 43,500 totalExercise: $14.00Exp: 2035-01-02→ Ordinary Shares (43,500 underlying) - Award
Ordinary Shares
2025-01-02+17,500→ 36,741 total - Sale
Ordinary Shares
2025-01-02$14.09/sh−1,750$24,658→ 34,991 total - Sale
Ordinary Shares
2025-01-06$15.00/sh−2,686$40,290→ 32,146 total
Footnotes (7)
- [F1]Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2026 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.
- [F2]Each RSU represents a contingent right to receive one ordinary share.
- [F3]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.90 to $14.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5).
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.69 to $14.75 inclusive.
- [F6]This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024.
- [F7]This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2026 and the remaining shares in 36 equal monthly installments thereafter.
Documents
Issuer
BICYCLE THERAPEUTICS PLC
CIK 0001761612
Entity typeother
Related Parties
1- filerCIK 0001983944
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:30 PM ET
- Size
- 20.0 KB